Cargando…
Design and prediction of new anticoagulants as a selective Factor IXa inhibitor via three-dimensional quantitative structure-property relationships of amidinobenzothiophene derivatives
Factor IXa (FIXa), a blood coagulation factor, is specifically inhibited at the initiation stage of the coagulation cascade, promising an excellent approach for developing selective and safe anticoagulants. Eighty-four amidinobenzothiophene antithrombotic derivatives targeting FIXa were selected to...
Autores principales: | Gao, Jia-Suo, Tong, Xu-Peng, Chang, Yi-Qun, He, Yu-Xuan, Mei, Yu-Dan, Tan, Pei-Hong, Guo, Jia-Liang, Liao, Guo-Chao, Xiao, Gao-Keng, Chen, Wei-Min, Zhou, Shu-Feng, Sun, Ping-Hua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4376188/ https://www.ncbi.nlm.nih.gov/pubmed/25848211 http://dx.doi.org/10.2147/DDDT.S75282 |
Ejemplares similares
-
Regulation of collective cell migration by RhoGAP myosin IXA
por: Omelchenko, Tatiana
Publicado: (2012) -
Preclinical and translational evaluation of coagulation factor IXa as a novel therapeutic target
por: Ankrom, Wendy, et al.
Publicado: (2016) -
Myosin IXa Binds AMPAR and Regulates Synaptic Structure, LTP, and Cognitive Function
por: Folci, Alessandra, et al.
Publicado: (2016) -
A new variant in PHKA2 is associated with glycogen storage disease type IXa
por: Rodríguez-Jiménez, Carmen, et al.
Publicado: (2017) -
A Structure Based Study of Selective Inhibition of Factor IXa over Factor Xa
por: Kundu, Sibsankar, et al.
Publicado: (2021)